VitiligoSymptoms, Doctors, Treatments, Advances & More
Learn About Vitiligo
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Sunnyvale Center (401)
Amit Pandya is a Dermatologist practicing medicine in Sunnyvale, California. Dr. Pandya is rated as an Elite provider by MediFind in the treatment of Vitiligo. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Porphyria Cutanea Tarda, Melasma, and Thrombectomy. Dr. Pandya is board certified in Dermatology. Dr. Pandya is currently accepting new patients.
Anuradha Bishnoi, MD, specializes in dermatology. She practices at UPMC North Hills Dermatology and UPMC Shadyside Dermatology. Dr. Bishnoi received her medical degree from Maharshi Dayanand University and completed her residency at the Postgraduate Institute of Medical Education and Research. Dr. Bishnoi is rated as an Elite provider by MediFind in the treatment of Vitiligo. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Hypomelanotic Disorder, Vitiligo, Lichen Planus, and Melasma.
Hahnemann Campus
John Harris is a Dermatologist practicing medicine in Worcester, Massachusetts. Dr. Harris is rated as an Elite provider by MediFind in the treatment of Vitiligo. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Bullae, and Cutaneous Lupus Erythematosus (CLE).
Summary: Vitiligo is a long-term autoimmune condition that causes the skin to lose its color. The body's germ-fighting system (immune system) mistakenly attacks the skin cells (melanocytes) which produce the pigment that gives the skin color (melanin). This leads to the formation of patches of skin with less or no pigment (depigmentation). These patches can occur anywhere on the body. In the nonsegmental f...
Summary: The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.